ALL KEYWORDSMyelodysplastic Syndrome with Excess BlastsRelated SpecialistsShowing 3 of 12Lohith GowdaMDAmer ZeidanMBBS, MDNikolai PodoltsevMD, PhDMore Related SpecialistsRelated Fact SheetsMyelodysplastic SyndromesRelated Clinical TrialsShowing 2 of 6A Multi-phase, Dose-Escalation Followed by an Open-label, Randomized, Crossover Study of Oral ASTX030 (Cedazuridine and Azacitidine Given in Combination) Versus Subcutaneous Azacitidine in Subjects With Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML), or Acute Myeloid Leukemia (AML)Leukemia & Hematologic CancersMYELOMATCH: A Screening Study to Assign People with Myeloid Cancer to a Treatment Study or Standard of Care Treatment within myeloMATCH (MyeloMATCH Screening Trial)Leukemia & Hematologic CancersMore Related Clinical TrialsRelated DepartmentsShowing 3 of 5Yale Cancer CenterInternal MedicineLeukemia & Lymphoma ProgramMore Related Departments
